Author Archives: Jan Paschal

Cayson Acquisition (CAPNU) priced its small IPO – 6.0 million units at $10.00 each – to raise $60.0 million, as expected, on Thursday night, Sept. 19, 2024. The New York-based SPAC intends to focus its search for target businesses throughout Asia, the prospectus said. Cayson Acquisition is the second SPAC IPO priced this week and […]

Upstream Bio (UPB Proposed), a Phase 2 clinical biotech focused on severe respiratory disease, filed plans to raise up to $100 million in an IPO, according to its S-1 filing on Wednesday, Sept. 18, 2024. Upstream Bio said it intends to list its stock on the NASDAQ. Upstream Bio’s S-1 filing was disclosed late Wednesday […]

BioAge Labs Inc. (BIOA Proposed) unveiled the terms for its IPO today – Wednesday, Sept. 18, 2024 – on the same day that the Federal Reserve cut interest rates by 50 basis points – the first U.S. interest-rate cut in four years. BioAge is offering 7.5 million shares at a price range of $17.00 to $19.00 […]

Yuanbao Inc. (YB Proposed) – the largest independent insurance distributor in China’s personal life and A&H (accident and health) insurance market in terms of first-year premiums in 2023, according to Frost & Sullivan – filed plans for its U.S. IPO today – Tuesday, Sept. 17, 2024. The Beijing-based insurance holding company did not disclose its […]

Guardian Pharmacy Services (GRDN Proposed) unveiled the terms for its $101.3 million IPO today – Monday, Sept. 16, 2024 – and launched the deal for pricing next week. The Atlanta-based pharmacy services company is offering 6.75 million shares at a price range of $14.00 to $16.00 to raise $101.25 million, if priced at the $15.00 […]

Denver-based BKV Corp. (BKV Proposed), a U.S. natural gas and NGL producer active mostly in the Barnett  Shale in the Fort Worth  Basin in Texas, disclosed the terms for its $300 million IPO early today – Monday, Sept. 16, 2024. BKV Corp. is offering 15.0 million shares at a price range of $19.00 to $21.00 […]

Zenas BioPharma (ZBIO) upsized its IPO at pricing to 13.24 million shares (13,235,294 shares) – up from 11.76 million shares in the prospectus – and priced its IPO at $17.00 – the mid-point of its $16.00-to-$18.00 price range – to raise $225.0 million on Thursday night, Sept. 12, 2024. At pricing, Zenas BioPharma increased the […]

Bicara Therapeutics (BCAX) increased its IPO’s size at pricing to 17.5 million shares – up from 14.71 million shares – and priced the IPO at $18.00 – the top of its $16.00-to-$18.00 range – to raise $315 million on Thursday night, Sept. 12, 2024. This was the second time that Bicara Therapeutics had upsized its […]

MBX Biosciences (MBX) upsized its IPO to 10.2 million shares – up from 8.5 million shares in the prospectus – and priced the deal at $16.00 – the top of its $14.00-to-$16.00 range – to raise $163.2 million on Thursday night, Sept. 12, 2024. At pricing, MBX Biosciences increased the IPOs size by 20 percent. Shares […]

Galaxy Payroll Group Ltd. (GLXG) of Hong Kong downsized its IPO at pricing – to 1.75 million shares – down from 2.0 million shares in the prospectus – and priced the deal at $4.00, as expected – to raise $7.0 million on Wednesday night, Sept. 11, 2024. Galaxy Payroll’s stock started trading today – Thursday, […]